Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.

Saved in:
Bibliographic Details
Title: Reply to Kunoe (2020) and Ghosh & Singh (2020) regarding Nunes et al. (2020): Opioid use and dropout from extended-release naltrexone in a controlled trial: implications for mechanism.
Authors: Nunes EV; New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA., Bisaga A; New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA., Krupitsky E; St Petersburg Pavlov State Medical University, St Petersburg, Russia.; Department of Addictions, V.M. Bekhterev National Medical Research Center for Psychiatry and Neurology, St Petersburg, Russia., Nangia N; Alkermes, Inc., Waltham, MA, USA., Silverman BL; Alkermes, Inc., Waltham, MA, USA., Akerman SC; Alkermes, Inc., Waltham, MA, USA., Sullivan MA; New York State Psychiatric Institute, Columbia University Irving Medical Center, New York, NY, USA.; Alkermes, Inc., Waltham, MA, USA.
Source: Addiction (Abingdon, England) [Addiction] 2020 Nov; Vol. 115 (11), pp. 2188-2190. Date of Electronic Publication: 2020 Jul 16.
Publication Type: Letter; Comment
Journal Info: Publisher: Wiley-Blackwell Country of Publication: England NLM ID: 9304118 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1360-0443 (Electronic) Linking ISSN: 09652140 NLM ISO Abbreviation: Addiction Subsets: MEDLINE
Database: MEDLINE Ultimate
Full text is not displayed to guests.
Be the first to leave a comment!
You must be logged in first